The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 30,183,895 | 22,032,040 | SH | SOLE | 22,032,040 | 0 | 0 | |||
| AN2 THERAPEUTICS INC | COM | 037326105 | 815,436 | 715,295 | SH | DFND | 0 | 715,295 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 41,009,686 | 3,457,815 | SH | SOLE | 3,457,815 | 0 | 0 | |||
| BIOHAVEN LTD | COM | G1110E107 | 5,708,732 | 505,645 | SH | SOLE | 505,645 | 0 | 0 | |||
| BOLT BIOTHERAPEUTICS INC | COM NEW | 097702203 | 171,176 | 31,305 | SH | DFND | 0 | 31,305 | 0 | |||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 6,776,526 | 2,411,575 | SH | SOLE | 2,411,575 | 0 | 0 | |||
| CARIBOU BIOSCIENCES INC | COM | 142038108 | 7,457,785 | 4,690,431 | SH | SOLE | 4,690,431 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 34,849,754 | 349,406 | SH | SOLE | 349,406 | 0 | 0 | |||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 2,053 | 247 | SH | SOLE | 247 | 0 | 0 | |||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 22,279 | 2,681 | SH | DFND | 0 | 2,681 | 0 | |||
| NEXTCURE INC | COM NEW | 65343E207 | 376,560 | 26,537 | SH | SOLE | 26,537 | 0 | 0 | |||
| NEXTCURE INC | COM NEW | 65343E207 | 1,860,437 | 131,109 | SH | DFND | 0 | 131,109 | 0 | |||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 43,978,494 | 5,376,344 | SH | SOLE | 5,376,344 | 0 | 0 | |||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 6,845,102 | 5,952,263 | SH | SOLE | 5,952,263 | 0 | 0 | |||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 1,242,583 | 1,080,507 | SH | DFND | 0 | 1,080,507 | 0 | |||
| Q32 BIO INC | COM | 746964105 | 922,220 | 277,777 | SH | SOLE | 277,777 | 0 | 0 | |||
| SENSEONICS HLDGS INC | COM | 81727U105 | 11,983 | 2,171 | SH | DFND | 0 | 2,171 | 0 | |||
| SPERO THERAPEUTICS INC | COM | 84833T103 | 5,504,271 | 2,362,348 | SH | SOLE | 2,362,348 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 31,875,000 | 1,875,000 | SH | DFND | 0 | 1,875,000 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 1,287,675 | 953,834 | SH | SOLE | 953,834 | 0 | 0 | |||
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 15,562,915 | 2,970,022 | SH | SOLE | 2,970,022 | 0 | 0 | |||